In Vivo Antigen Stability Affects DNA Vaccine Immunogenicity

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Journal of Immunology

• Publication date

  2007-08-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.4049/jimmunol.179.4.2126PMID 17675471
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Induction of Multifunctional Human Immunodeficiency Virus Type 1 (HIV-1)-Specific T Cells Capable of Proliferation in Healthy Subjects by Using a Prime-Boost Regimen of DNA- and Modified Vaccinia Virus Ankara-Vectored Vaccines Expressing HIV-1 Gag Coupled to CD8+ T-Cell Epitopes

  2006cited by this paper
• Enhancing immunogenicity by limiting susceptibility to lysosomal proteolysis

  2006cited by this paper
• Effects of lysine to arginine mutations in HIV-1 Vif on its expression and viral infectivity.

  2006cited by this paper
• A rapid, reversible, and tunable method to regulate protein function in living cells using synthetic small molecules.

  2006cited by this paper
• Design and preclinical evaluation of a multigene human immunodeficiency virus type 1 subtype C DNA vaccine for clinical trial.

  2006cited by this paper
• Cross-presentation by intercellular peptide transfer through gap junctions

  2005cited by this paper
• Apoptotic Cells Deliver Processed Antigen to Dendritic Cells for Cross-Presentation

  2005cited by this paper
• Peptides chaperoned by heat-shock proteins are a necessary and sufficient source of antigen in the cross-priming of CD8+ T cells

  2005cited by this paper
• A rapid and potent DNA vaccination strategy defined by in vivo monitoring of antigen expression

  2005cited by this paper
• Prime-boost vaccination with plasmid DNA and a chimeric adenovirus type 5 vector with type 35 fiber induces protective immunity against HIV

  2005cited by this paper
• Cross‐presentation: underlying mechanisms and role in immune surveillance

  2005cited by this paper
• A Family of Mammalian E3 Ubiquitin Ligases That Contain the UBR Box Motif and Recognize N-Degrons

  2005cited by this paper
• Cross-Presentation of the Long-Lived Lymphocytic Choriomeningitis Virus Nucleoprotein Does Not Require Neosynthesis and Is Enhanced via Heat Shock Proteins1

  2005cited by this paper
• Cross‐presentation, dendritic cell subsets, and the generation of immunity to cellular antigens

  2004cited by this paper
• Development of novel vaccines using DNA shuffling and screening strategies.

  2004cited by this paper
• CD8+ T Cell Cross-Priming via Transfer of Proteasome Substrates

  2004cited by this paper
• Antigen Bias in T Cell Cross-Priming

  2004cited by this paper
• Engineering RENTA, a DNA prime-MVA boost HIV vaccine tailored for Eastern and Central Africa

  2004cited by this paper
• Recombinant modified vaccinia virus Ankara expressing antigen 85A boosts BCG-primed and naturally acquired antimycobacterial immunity in humans

  2004cited by this paper
• A major role for TPPII in trimming proteasomal degradation products for MHC class I antigen presentation.

  2004cited by this paper
• Cellular protein is the source of cross-priming antigen in vivo.

  2004cited by this paper
• Cutting Edge: Efficient MHC Class I Cross-Presentation during Early Vaccinia Infection Requires the Transfer of Proteasomal Intermediates between Antigen Donor and Presenting Cells 1

  2003cited by this paper
• Direct Priming and Cross-Priming Contribute Differentially to the Induction of CD8+ CTL Following Exposure to Vaccinia Virus Via Different Routes1

  2002cited by this paper
• Danger signals: SOS to the immune system.

  2001cited by this paper
• Cross-Priming as a Predominant Mechanism for Inducing CD8+ T Cell Responses in Gene Gun DNA Immunization1

  2001cited by this paper
• Modified HPV16 E7 Genes as DNA Vaccine against E7-Containing Oncogenic Cells.

  2001cited by this paper
• Multiple C-Terminal Lysine Residues Target p53 for Ubiquitin-Proteasome-Mediated Degradation

  2000cited by this paper
• Regulation of protein secretion through controlled aggregation in the endoplasmic reticulum.

  2000cited by this paper
• In vivo priming by DNA injection occurs predominantly by antigen transfer.

  1999cited by this paper
• Maturation of dendritic cells accompanies high-efficiency gene transfer by a CD40-targeted adenoviral vector.

  1999cited by this paper
• Cytotoxic T cell responses to DNA vaccination: dependence on antigen presentation via class II MHC.

  1998influential reference
• Using ubiquitin to follow the metabolic fate of a protein.

  1996cited by this paper
• Induction of cytotoxic T lymphocytes by intramuscular immunization with plasmid DNA is facilitated by bone marrow-derived cells.

  1996cited by this paper
• Signal Sequence Processing in Rough Microsomes (*)

  1995cited by this paper
• Endogenous antigen presentation by MHC class II molecules

  1994cited by this paper
• Different roles of αβ and γδ T cells in immunity against an intracellular bacterial pathogen

  1993cited by this paper
• Depletion of CD4+ T cells in major histocompatibility complex class II-deficient mice

  1991cited by this paper
• Cellular peptide composition governed by major histocompatibility complex class I molecules

  1990cited by this paper
• Class I MHC can present an endogenous peptide to cytotoxic T lymphocytes

  1989cited by this paper
• In vivo half-life of a protein is a function of its amino-terminal residue.

  1986cited by this paper
• Cytotoxic T cells recognize fragments of the influenza nucleoprotein.

  1985cited by this paper
• Minor H antigens introduced on H-2 different stimulating cells cross-react at the cytotoxic T cell level during in vivo priming.

  1976cited by this paper
• Reprints Available Directly from the Publisher Photocopying Permitted by License Only Positive and Negative Selection in Transgenic Mice Expressing a T-cell Receptor Specific for Influenza Nucleoprotein and Endogenous Superantigen

  year unknowncited by this paper

• Dendritic cell-based vaccine prepared with recombinant Lactococcus lactis eukaryotic-prokaryotic dual expressing OVA enhances antitumor efficacy by both direct and cross-presentation.

  2025cites this paper
• Single Amino Acid Deletion at N-Terminus of the Target Antigen in DNA Vaccine Induces Altered CD8+ T Cell Responses against Tumor Antigen

  2021cites this paper
• Nucleic Acid-Based Approaches for Tumor Therapy

  2020cites this paper
• DNA Vaccines—How Far From Clinical Use?

  2018cites this paper
• Development of a Molecular Adjuvant to Enhance Antigen-Specific CD8+ T Cell Responses

  2018cites this paper
• Characterizing neoantigens for personalized cancer immunotherapy.

  2017cites this paper
• Dermal Delivery of Constructs Encoding Cre Recombinase to Induce Skin Tumors in PtenLoxP/LoxP;BrafCA/+ Mice

  2016cites this paper
• DNA Vaccines Delivered By Microneedle and Tattoo Gun Induce Protective Immune Responses to Hla-A2.1 Restricted CRPV E1 and HPV16e7 Epitopes in HLA-A2.1 Transgenic Rabbits

  2016cites this paper
• B lymphocytes as direct antigen-presenting cells for anti-tumor DNA vaccines

  2016cites this paper
• Increased Protein Degradation Improves Influenza Virus Nucleoprotein-Specific CD8+ T Cell Activation In Vitro but Not in C57BL/6 Mice

  2016cites this paper
• Recent insights into cutaneous immunization: How to vaccinate via the skin.

  2015cites this paper
• Artificially synthesized helper/killer-hybrid epitope long peptide (H/K-HELP): preparation and immunological analysis of vaccine efficacy.

  2015cites this paper
• Antigen design enhances the immunogenicity of Semliki Forest virus-based therapeutic human papillomavirus vaccines

  2015cites this paper
• Strategies for improving DNA vaccine performance.

  2014cites this paper
• Intradermal vaccination by DNA tattooing.

  2014cites this paper
• Long-peptide therapeutic vaccination against CRPV-induced papillomas in HLA-A2.1 transgenic rabbits.

  2014cites this paper
• Molecular medicine : Promises and patience 107

  2013cites this paper
• Minicircle DNA is superior to plasmid DNA in eliciting antigen-specific CD8+ T-cell responses.

  2013cites this paper
• Recent advances towards the clinical application of DNA vaccines.

  2013cites this paper
• Intradermal Immunization

  2012cites this paper
• Fusion of the Mycobacterium tuberculosis Antigen 85A to an Oligomerization Domain Enhances Its Immunogenicity in Both Mice and Non-Human Primates

  2012cites this paper
• DNA vaccines and intradermal vaccination by DNA tattooing.

  2012cites this paper
• Fusion of the Mycobacteriumtuberculosis Antigen 85A to an Oligomerization Domain Enhances Its Immunogenicity in Both Mice and Non-Human Primates

  2012cites this paper
• RATIONAL DESIGN OF DNA VACCINES FOR THE INDUCTION OF HPV16 E6 AND E7 SPECIFIC CYTOTOXIC T CELL RESPONSES

  2012influential citation
• Enhancement of antibody responses to native G protein-coupled receptors using E. coli GroEL as a molecular adjuvant in DNA immunization.

  2012cites this paper
• DNA and Modified Vaccinia Virus Ankara Vaccines Encoding Multiple Cytotoxic and Helper T-Lymphocyte Epitopes of Human Immunodeficiency Virus Type 1 (HIV-1) Are Safe but Weakly Immunogenic in HIV-1-Uninfected, Vaccinia Virus-Naive Adults

  2012cites this paper
• Development and Characterization of a novel Immunotherapy against Prostate Cancer

  2012cites this paper
• Rational Design of DNA Vaccines for the Induction of Human Papillomavirus Type 16 E6- and E7-Specific Cytotoxic T-Cell Responses

  2012influential citation
• Stable Antigen Is Most Effective for Eliciting CD8+ T-Cell Responses after DNA Vaccination and Infection with Recombinant Vaccinia Virus In Vivo

  2012cites this paper
• Targeting the human immunodeficiency virus type-1 Gag protein into the defective ribosomal product pathway enhances its MHC cl

  2011cites this paper
• Improved Innate and Adaptive Immunostimulation by Genetically Modified HIV-1 Protein Expressing NYVAC Vectors

  2011cites this paper
• Preclinical development of highly effective and safe DNA vaccines directed against HPV 16 E6 and E7

  2011cites this paper
• Injection site‐dependent induction of immune response by DNA vaccine: comparison of skin and spleen as a target for vaccination

  2010cites this paper
• Delivery of Exogenous Antigens to Induce Cytotoxic CD8+ T Lymphocyte Responses

  2010cites this paper
• DNA vaccination in oncology: current status, opportunities and perspectives.

  2010cites this paper
• Designing CD8+ T cell vaccines: it's not rocket science (yet).

  2010cites this paper
• Development of a novel Hsp70-based DNA vaccine as a multifunctional antigen delivery system.

  2010cites this paper
• ANALYSIS OF LYMPHOCYTIC CHORIOMENINGITIS VIRUS ANTIGENS PRESENTATION BY MACROPHAGES

  2010cites this paper
• Synthetic vehicles for DNA vaccination

  2009cites this paper
• MHC ligand generation in T cell-mediated immunity and MHC multimer technologies for T cell detection

  2009cites this paper
• Construction of a triple modified p53 containing DNA vaccine to enhance processing and presentation of the p53 antigen.

  2009cites this paper
• Formulation and delivery of dermal DNA vaccines

  2009cites this paper
• MHC class I assembly: out and about.

  2008cites this paper
• Mechanisms of immunization against cancer using chimeric antigens.

  2008cites this paper
• Enhancement of T cell-mediated and humoral immunity of beta-glucuronidase-based DNA vaccines against HPV16 E7 oncoprotein.

  2008cites this paper
• Evaluation of novel vaccine candidates against tuberculosis in murine models of persistent and latent infection

  2008cites this paper
• Cancer immunotherapy by dendritic cells.

  2008cites this paper
• Modifying the HIV-1 env gp160 gene to improve pDNA vaccine-elicited cell-mediated immune responses.

  2008cites this paper
• Optimization of Intradermal Vaccination by DNA Tattooing in Human Skin

  2008cites this paper
• Bioorthogonal antigens as tool for investigation of antigen processing and presentation

  year unknowncites this paper